At all time-points prior to HCC diagnosis, levels of serological markers had elevated, but there were more patients of PIVKA-II+ alone than AFP+ alone, and 6 months before diagnosis seems the best time for HCC prediction using PIVKA-II with a positive rate of 51.0%. The gene discussed is AFP; the disease is hepatocellular carcinoma.